HealthSouth Corporation (NYSE:HLS) was downgraded by analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Thursday, July 13th.

HLS has been the topic of several other research reports. KeyCorp initiated coverage on HealthSouth Corporation in a report on Thursday, June 15th. They set a “sector weight” rating on the stock. Zacks Investment Research upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating and set a $55.00 target price on the stock in a research note on Thursday, June 29th. ValuEngine upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating in a research note on Friday, July 7th. Royal Bank Of Canada reiterated a “buy” rating and issued a $53.00 target price on shares of HealthSouth Corporation in a research note on Wednesday, July 5th. Finally, Barclays PLC reiterated an “underweight” rating and issued a $46.00 target price (up previously from $44.00) on shares of HealthSouth Corporation in a research note on Monday, May 1st. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating and seven have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $48.83.

Shares of HealthSouth Corporation (NYSE HLS) opened at 43.68 on Thursday. HealthSouth Corporation has a one year low of $36.97 and a one year high of $49.71. The firm has a market capitalization of $3.94 billion, a price-to-earnings ratio of 15.92 and a beta of 0.61. The company’s 50 day moving average is $46.14 and its 200-day moving average is $44.07.

HealthSouth Corporation (NYSE:HLS) last issued its quarterly earnings data on Monday, July 31st. The company reported $0.71 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.68 by $0.03. The business had revenue of $981.30 million for the quarter, compared to analysts’ expectations of $976.46 million. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The company’s revenue for the quarter was up 6.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.69 EPS. Equities analysts expect that HealthSouth Corporation will post $2.71 EPS for the current year.

ILLEGAL ACTIVITY NOTICE: This article was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/09/healthsouth-corporation-hls-downgraded-to-sell-at-bidaskclub-updated-updated-updated.html.

In related news, CEO Mark J. Tarr sold 22,625 shares of HealthSouth Corporation stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the transaction, the chief executive officer now directly owns 283,134 shares in the company, valued at $12,174,762. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.60% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. First Mercantile Trust Co. raised its stake in shares of HealthSouth Corporation by 18.8% in the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock valued at $132,000 after buying an additional 430 shares during the last quarter. Neuburgh Advisers LLC raised its stake in shares of HealthSouth Corporation by 40.1% in the first quarter. Neuburgh Advisers LLC now owns 3,072 shares of the company’s stock valued at $132,000 after buying an additional 880 shares during the last quarter. Glen Harbor Capital Management LLC raised its stake in shares of HealthSouth Corporation by 40.1% in the first quarter. Glen Harbor Capital Management LLC now owns 4,224 shares of the company’s stock valued at $181,000 after buying an additional 1,210 shares during the last quarter. HL Financial Services LLC acquired a new stake in shares of HealthSouth Corporation during the second quarter valued at approximately $213,000. Finally, BB&T Corp acquired a new stake in shares of HealthSouth Corporation during the first quarter valued at approximately $200,000. Institutional investors own 97.96% of the company’s stock.

HealthSouth Corporation Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Stock Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related stocks with our FREE daily email newsletter.